Midday Wave #15 Neutral

Midday Wave #15: 196 Bulls vs. 24% Breadth: Which Number Is Lying? – Monday 3/16/2026

March 16, 2026 4:07

Tickers Mentioned

CCUP COGT ACRS CIEN IMMX BABA META CF NBIG

Episode Summary

Breadth has contracted to just 24% of stocks above their 20-day SMA — even as 196 names flash bullish signals. The team breaks down what the divergence means for afternoon positioning, which high-RVOL names are worth watching, and why META at $613.71 is the session's defining level.

Key Takeaways

Tech bouncing 1.73% from 15th percentile weakness
Only 24% of stocks above 20-day averages
Healthcare leading SIP momentum with FDA approvals
Energy sector holding 90th percentile strength
Mixed signals suggest cautious afternoon trading

Midday Situation Check

Mixed regime emerging as bullish 4% sentiment (196 names) battles underlying weakness with only 24% of stocks above 20-day averages.

Market Recap — Session So Far

Market showing choppy action with tech attempting recovery while broader sectors struggle

Technology bouncing 1.73% today after sliding into 15th percentile rank, attempting reversal from recent weakness
Market breadth remains concerning with Bull 4% at 196 vs Bear 4% at 55, but only 24% above 20 SMA signals underlying deterioration
Energy holding strong at 4.72 (90th percentile), providing defensive anchor as Consumer Discretionary slides to 3rd percentile at -1.49

Momentum Watch — Breakout Continuation & SIP

CCUP leading with 18.2% surge and 1.0 RVOL, showing strong institutional interest in MISC sector breakout
Healthcare names dominating SIP activity: COGT up on FDA drug approval, ACRS gaining 5.7% with medical sector rotation
CIEN standout with 7.8% gain and 1.3 RVOL in telecom, institutional-backed momentum continuing from morning

Strategy Check — Continuation, SIP & 20% Study

IMMX showing explosive 7.7% move with 2.2 RVOL, highest continuation signal maintaining momentum in medical sector
BABA appearing in SIP with Ant Group acquisition approval, adding 2.0 sentiment boost to retail sector rotation
20% Study highlighting ETF momentum in NBIG with 167% above 52-week lows and 3.63 RVOL, confirming institutional flows

Quick Takes & Wrap-Up

META at $613.71 testing support after workforce reduction news — key level to hold for afternoon tech recovery
CF at $129.57 under pressure from litigation settlement — watch for bounce if sector energy holds
Cautious bullish bias for afternoon session as 196 bull names provide cushion, but watch 24% breadth level for confirmation

Welcome to WaveRider Midday Wave, your mid-session market intelligence. Let's dive in. 196 stocks are flashing bullish signals right now, but only 24% of the market is trading above its 20-day average. One of those numbers is telling you the truth about this afternoon. Let's find out which one. Yeah. So, morning regime was cautious at 48% above SMA40. Where do we stand now, and has the picture improved or gotten worse? Okay, so breath has actually contracted since this morning. We're down to just 24% above the 20-day SMA. Wait, so it got worse since this morning? Exactly. That's the opposite of what 196 bull names would suggest. I mean, it's like the bull count is the fresh paint on the facade, but the 24% breath? That's the cracks underneath. Right, right. Mm-hmm. The gains are concentrating in fewer and fewer names. Classic late narrowing Right Yeah And you know sector rotation what that telling us about the character of this move Energy anchoring at the 90th percentile 4 reading while consumer discretionary has collapsed Yeah, I saw that. What's the spread? Like 80 something percentiles? 87. Exactly. And that gap is money hiding, not hunting. Then you've got tech attempting a 1.73 percent bounce, but from the 15th percentile rank. You know, that's a reversal attempt from deeply oversold territory, not a confirmed trend change. Mm-hmm. Huh. So the broad market is narrowing, but within that narrowing, there are specific names generating real institutional activity. Which signal actually has the volume? Behind it. IMMX, full stop. 7.7% move, 2.2 R vol. That's the highest relative volume continuation signal of the session. In medical. Medical, yeah. And honestly, it fits the defensive rotation perfectly. Healthcare is acting like a lifeboat right now not a risk ban Yeah totally So 2 R vol on a continuation that con Conviction yes But I add one caveat You also getting a defensive rotation tailwind in the sector The RVOL is real but context matters This isn a pure momentum play Right. Okay, fair. What else is on your screen? C-I-E-N at plus 7.8% with 1.3 R-VOL in telecom, second institutional-backed continuation name from the morning. And ACRS is worth a mention too, plus 5.7% on the same medical rotation theme, reinforces the healthcare story. That tracks. Yeah. What about stocks in play? Look, COGT moving on an FDA drug approval, hardest kind of catalyst, regulatory. That's exactly why money is rotating there rather than chasing broad exposure. And BABA. And BABA, that's a different animal than the healthcare names, right? Totally different risk profile. Ant Group acquisition approval, 2 sentiment boost worth monitoring but I wouldn put it in the same bucket Sure Got it What the 20 study showing at the broader level NBIG ETF flagged at 167 above its 52 lows with 3 R vol And look, you know that level of relative volume in an ETF is programmatic institutional flow. That's not retail. No kidding. 3.63. Oh, wow. Confirms smart money is concentrating into specific momentum pockets, not broad market exposure. Mm-hmm. So, honestly, signals are concentrated. Breath is narrow. How does a trader actually adjust their afternoon plan from what they set up this morning? Honestly, the core adjustment is straightforward. Shift from any broad bullish exposure to strictly selective, catalyst-driven, high-RVOL names. I mean, three out of four stocks just not participating in this rally, that's not a rally. That's a mirage. Yeah, yeah. That's all for today's episode of WaveRider Midday Wave, your mid-session market intelligence. See you next time.